2024

Motion to Terminate the Funding Payment Agreement and Settlement Facility
  1. Motion to Terminate the Funding Payment Agreement and Settlement Facility, Nov. 15, 2024, ECF
    #1796


    1. Exhibit 1 - Amended Joint Plan
      #1796-1


    2. Exhibit 2 - Funding Payment Agreement
      #1796-2


    3. Exhibit 3 - Settlement Facility Agreement
      #1796-3


    4. Exhibit 4 - Declaration of Brian Chmiel
      #1796-4


    5. Exhibit 5 - Annex A, Claims Resolultion Procedures
      #1796-5


    6. Exhibit 6 - 2nd Amended Restated Depository Trust Agreement
      #1796-6


    7. Exhibit 7 - Declaration of Kimberly Smith-Mair
      #1796-7


    8. Exhibit 8 - Declaration of John Wills
      #1796-8


  2. Cross-Motion by Korean Claimants To Deny Motion to Terminate Funding Pursuant to Section 2.01(c) of the Funding Payment Agreement, Nov. 27, 2024 ECF
    #1802


    1. Index of Exhibits to Korean Claimants Cross-Motion ECF
      #1802-1


    2. Exhibit A to Korean Claimants Cross Motion ECF
      #1802-2


    3. Exhibit B to Korean Claimants Cross Motion
      (not accessible because it contains claimant information)


  3. CAC Response to Motion to Terminate Funding, Dec. 6, 2024 ECF
    #1806


  4. Dow and Finance Cmte Reply to Korean Claimants, Dec. 9, 2024, ECF
    #1807


    1. Exhibit 1, ECF
      #1807-1


  5. Dow and Finance Cmte Motion to File Excess Pages in their Reply to Korean Claimants, Dec 9, 2024 ECF
    #1808


  6. Dow and Finance Cmte Reply to Korean Claimants, Dec. 9, 2024, ECF
    #1809
    (document and exhibits have been ordered withdrawn from the docket and is not available)


    1. Exhibit 1, ECF
      #1809-1


    2. Exhibit 2, ECF
      #1809-2


  7. Reply of Korean Claimants, Dec. 10, 2024 ECF
    #1812


  8. CAC Motion for Leave to File Sur-Reply, Dec. 18, 2024 ECF
    #1814


    1. Exhibit 1, Proposed Sur-Reply, ECF
      #1814-1


    2. Exhibit 2, Proposed Exhibits to Sur-Reply, ECF
      #1814-2


    3. Exhibit 3, Proposed Order, ECF
      #1814-3


  9. Dow and Finance Cmte Motion to File Materials Under Seal, Dec. 21, 2024 ECF
    #1815


  10. Dow and Finance Cmte Redacted Reply to CAC Response (ECF 1806), Dec. 21, 2024, ECF
    #1817


    1. Index of Exhibits, ECF
      #1817-1


    2. Exhibit 1, N. Blount Declaration, ECF
      #1817-2


    3. Exhibit 2, Redacted Declaration of B Chmiel, ECF
      #1817-3


  11. Dow and Finance Cmte Motion to Strike/Remove Their Reply to CAC (ECF 1809), Dec. 21, 2024 ECF
    #1818


  12. Korean Motion to Strike Reply (ECF 1811), Dec. 22, 2024 ECF
    #1819


  13. CAC Sur-Reply to Dow and Finance Cmte Reply, Dec. 23, 2024 ECF
    #1824


    1. Index of Exhibits ECF
      #1824-1


    2. Exhibit 1 - July 16, 2004 Order (ECF 125) ECF
      #1824-2


    3. Exhibit 2 - Sept. 29, 2023 Order (ECF 1734) ECF
      #1824-3


    4. Exhibit 3 - Nov. 27, 2024 Order (ECF 1801) ECF
      #1824-4


    5. Exhibit 4 - Dec. 21, 2006 Order (ECF 476) ECF
      #1824-5


    6. Exhibit 5 - Dec. 17. 2021 Order (ECF 1635) ECF
      #1824-6


    7. Exhibit 6 - Declaration of CAC ECF
      #1824-7


    8. Exhibit 7 - Sept. 29, 2023 Order (ECF 1737) ECF
      #1824-8


  14. Notice of Proposed Findings and Conclusions from Dow and Finance Cmte, Dec. 24, 2024 ECF
    #1825


    1. Exhibit 1, ECF
      #1825-1


  15. Dow and Finance Cmte Motion to File Sur-Sur Reply, Dec. 29, 2024 ECF
    #1826


  16. Order Granting Motion to Terminate Funding, Dec. 20, 2024 ECF
    #1827


  17. Dow Sur Sur Reply
    (document not available)


  18. Notice of Appeal by Korean Claimants, Jan. 1, 2025 ECF
    #1830




Obtaining Acrobat Reader
You can obtain a free copy of Acrobat Reader from Adobe's Web Site.

Using Acrobat Reader
After installing Acrobat Reader, double-click a PDF file to automatically start Acrobat Reader and view the file. Or you can start Acrobat Reader first, then choose File > Open to open and view a PDF file.

Support
If you encounter problems while downloading, installing or using Acrobat Reader, visit Adobe's Support Center for help.



© 2024 Claimants' Advisory Committee. All Rights Reserved.